デフォルト表紙
市場調査レポート
商品コード
1118231

世界のがん診断薬市場:考察と予測 (2028年まで)

Global Cancer Diagnostics Market Insights, Forecast to 2028

出版日: | 発行: QYResearch | ページ情報: 英文 104 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.55円
世界のがん診断薬市場:考察と予測 (2028年まで)
出版日: 2022年08月24日
発行: QYResearch
ページ情報: 英文 104 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、がん診断薬 (Cancer Diagnostics) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析:タイプ別
    • 世界のがん診断薬の市場規模成長率:タイプ別, 2017 VS 2021 VS 2028
    • Platform-based
    • Instrument-based
  • 市場:アプリケーション別
    • 世界のがん診断薬の市場規模成長率:アプリケーション別, 2017 VS 2021 VS 2028
    • Breast Cancer
    • Lung Cancer
    • Colorectal Cancer
    • Others
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界のがん診断薬の市場展望 (2017-2028)
  • がん診断薬の市場成長トレンド:地域別
    • がん診断薬 市場規模:地域別: 2017 VS 2021 VS 2028
    • がん診断薬の市場規模実績:地域別 (2017-2022)
    • がん診断薬の市場規模予測:地域別 (2023-2028)
  • がん診断薬 市場動向
    • がん診断薬 業界動向
    • がん診断薬 市場の促進要因
    • がん診断薬 市場の課題
    • がん診断薬 市場の抑制要因

第3章 競合情勢:主要企業別

  • 世界のがん診断薬の上位企業:収益別
    • 世界のがん診断薬の上位企業:収益別 (2017-2022)
    • 世界のがん診断薬の収益シェア:企業別 (2017-2022)
  • 世界のがん診断薬の市場シェア:企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング:がん診断薬の収益
  • 世界のがん診断薬 市場集中度
    • 世界のがん診断薬 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業: がん診断薬の収益 2021
  • がん診断薬の主要企業の本社および事業エリア
  • 主要企業 がん診断薬の製品ソリューションおよびサービス
  • 市場参入時期: がん診断薬 市場
  • M&A, 拡張計画

第4章 がん診断薬 内訳データ:タイプ別

  • 世界のがん診断薬の市場規模実績:タイプ別 (2017-2022)
  • 世界のがん診断薬の市場規模予測:タイプ別 (2023-2028)

第5章 がん診断薬 内訳データ:アプリケーション別

  • 世界のがん診断薬の市場規模実績:アプリケーション別 (2017-2022)
  • 世界のがん診断薬の市場規模予測:アプリケーション別 (2023-2028)

第6章 北米

  • 北米のがん診断薬 市場規模 (2017-2028)
  • 北米のがん診断薬 市場規模:タイプ別
    • 北米のがん診断薬 市場規模:タイプ別 (2017-2022)
    • 北米のがん診断薬 市場規模:タイプ別 (2023-2028)
    • 北米のがん診断薬の市場シェア:タイプ別 (2017-2028)
  • 北米のがん診断薬 市場規模:アプリケーション別
    • 北米のがん診断薬 市場規模:アプリケーション別 (2017-2022)
    • 北米のがん診断薬 市場規模:アプリケーション別 (2023-2028)
    • 北米のがん診断薬の市場シェア:アプリケーション別 (2017-2028)
  • 北米のがん診断薬 市場規模:国別
    • 北米のがん診断薬 市場規模:国別 (2017-2022)
    • 北米のがん診断薬 市場規模:国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州のがん診断薬 市場規模 (2017-2028)
  • 欧州のがん診断薬 市場規模:タイプ別
    • 欧州のがん診断薬 市場規模:タイプ別 (2017-2022)
    • 欧州のがん診断薬 市場規模:タイプ別 (2023-2028)
    • 欧州のがん診断薬の市場シェア:タイプ別 (2017-2028)
  • 欧州のがん診断薬 市場規模:アプリケーション別
    • 欧州のがん診断薬 市場規模:アプリケーション別 (2017-2022)
    • 欧州のがん診断薬 市場規模:アプリケーション別 (2023-2028)
    • 欧州のがん診断薬の市場シェア:アプリケーション別 (2017-2028)
  • 欧州のがん診断薬 市場規模:国別
    • 欧州のがん診断薬 市場規模:国別 (2017-2022)
    • 欧州のがん診断薬 市場規模:国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 がん診断薬 市場規模 (2017-2028)
  • アジア太平洋地域 がん診断薬 市場規模:タイプ別
    • アジア太平洋地域 がん診断薬 市場規模:タイプ別 (2017-2022)
    • アジア太平洋地域 がん診断薬 市場規模:タイプ別 (2023-2028)
    • アジア太平洋地域 がん診断薬の市場シェア:タイプ別 (2017-2028)
  • アジア太平洋地域 がん診断薬 市場規模:アプリケーション別
    • アジア太平洋地域 がん診断薬 市場規模:アプリケーション別 (2017-2022)
    • アジア太平洋地域 がん診断薬 市場規模:アプリケーション別 (2023-2028)
    • アジア太平洋地域 がん診断薬の市場シェア:アプリケーション別 (2017-2028)
  • アジア太平洋地域 がん診断薬 市場規模:地域別
    • アジア太平洋地域 がん診断薬 市場規模:地域別 (2017-2022)
    • アジア太平洋地域 がん診断薬 市場規模:地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカのがん診断薬 市場規模 (2017-2028)
  • ラテンアメリカのがん診断薬 市場規模:タイプ別
    • ラテンアメリカのがん診断薬 市場規模:タイプ別 (2017-2022)
    • ラテンアメリカのがん診断薬 市場規模:タイプ別 (2023-2028)
    • ラテンアメリカのがん診断薬の市場シェア:タイプ別 (2017-2028)
  • ラテンアメリカのがん診断薬 市場規模:アプリケーション別
    • ラテンアメリカのがん診断薬 市場規模:アプリケーション別 (2017-2022)
    • ラテンアメリカのがん診断薬 市場規模:アプリケーション別 (2023-2028)
    • ラテンアメリカのがん診断薬の市場シェア:アプリケーション別 (2017-2028)
  • ラテンアメリカのがん診断薬 市場規模:国別
    • ラテンアメリカのがん診断薬 市場規模:国別 (2017-2022)
    • ラテンアメリカのがん診断薬 市場規模:国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカのがん診断薬 市場規模 (2017-2028)
  • 中東・アフリカのがん診断薬 市場規模:タイプ別
    • 中東・アフリカのがん診断薬 市場規模:タイプ別 (2017-2022)
    • 中東・アフリカのがん診断薬 市場規模:タイプ別 (2023-2028)
    • 中東・アフリカのがん診断薬の市場シェア:タイプ別 (2017-2028)
  • 中東・アフリカのがん診断薬 市場規模:アプリケーション別
    • 中東・アフリカのがん診断薬 市場規模:アプリケーション別 (2017-2022)
    • 中東・アフリカのがん診断薬 市場規模:アプリケーション別 (2023-2028)
    • 中東・アフリカのがん診断薬の市場シェア:アプリケーション別 (2017-2028)
  • 中東・アフリカのがん診断薬 市場規模:国別
    • 中東・アフリカのがん診断薬 市場規模:国別 (2017-2022)
    • 中東・アフリカのがん診断薬 市場規模:国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • Becton, Dickinson and Company
  • GE Healthcare
  • Abbott
  • Roche
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Illumina
  • Siemens Healthcare
  • C.R. Bard

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global Cancer Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Platform-based
  • Table 3. Key Players of Instrument-based
  • Table 4. Global Cancer Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 5. Global Cancer Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 6. Global Cancer Diagnostics Market Size by Region (2017-2022) & (US$ Million)
  • Table 7. Global Cancer Diagnostics Market Share by Region (2017-2022)
  • Table 8. Global Cancer Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 9. Global Cancer Diagnostics Market Share by Region (2023-2028)
  • Table 10. Cancer Diagnostics Market Trends
  • Table 11. Cancer Diagnostics Market Drivers
  • Table 12. Cancer Diagnostics Market Challenges
  • Table 13. Cancer Diagnostics Market Restraints
  • Table 14. Global Cancer Diagnostics Revenue by Players (2017-2022) & (US$ Million)
  • Table 15. Global Cancer Diagnostics Revenue Share by Players (2017-2022)
  • Table 16. Global Top Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Diagnostics as of 2021)
  • Table 17. Ranking of Global Top Cancer Diagnostics Companies by Revenue (US$ Million) in 2021
  • Table 18. Global 5 Largest Players Market Share by Cancer Diagnostics Revenue (CR5 and HHI) & (2017-2022)
  • Table 19. Key Players Headquarters and Area Served
  • Table 20. Key Players Cancer Diagnostics Product Solution and Service
  • Table 21. Date of Enter into Cancer Diagnostics Market
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
  • Table 24. Global Cancer Diagnostics Revenue Market Share by Type (2017-2022)
  • Table 25. Global Cancer Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 26. Global Cancer Diagnostics Revenue Market Share by Type (2023-2028)
  • Table 27. Global Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
  • Table 28. Global Cancer Diagnostics Revenue Share by Application (2017-2022)
  • Table 29. Global Cancer Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 30. Global Cancer Diagnostics Revenue Share by Application (2023-2028)
  • Table 31. North America Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
  • Table 32. North America Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
  • Table 33. North America Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
  • Table 34. North America Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
  • Table 35. North America Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
  • Table 36. North America Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
  • Table 37. Europe Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
  • Table 38. Europe Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
  • Table 39. Europe Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
  • Table 40. Europe Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
  • Table 41. Europe Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
  • Table 42. Europe Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
  • Table 43. Asia Pacific Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
  • Table 44. Asia Pacific Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Cancer Diagnostics Market Size by Region (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Cancer Diagnostics Market Size by Region (2023-2028) & (US$ Million)
  • Table 49. Latin America Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
  • Table 50. Latin America Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
  • Table 51. Latin America Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
  • Table 52. Latin America Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
  • Table 53. Latin America Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
  • Table 54. Latin America Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
  • Table 55. Middle East and Africa Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
  • Table 56. Middle East and Africa Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
  • Table 61. Becton, Dickinson and Company Company Details
  • Table 62. Becton, Dickinson and Company Business Overview
  • Table 63. Becton, Dickinson and Company Cancer Diagnostics Product
  • Table 64. Becton, Dickinson and Company Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million)
  • Table 65. Becton, Dickinson and Company Recent Developments
  • Table 66. GE Healthcare Company Details
  • Table 67. GE Healthcare Business Overview
  • Table 68. GE Healthcare Cancer Diagnostics Product
  • Table 69. GE Healthcare Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million)
  • Table 70. GE Healthcare Recent Developments
  • Table 71. Abbott Company Details
  • Table 72. Abbott Business Overview
  • Table 73. Abbott Cancer Diagnostics Product
  • Table 74. Abbott Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million)
  • Table 75. Abbott Recent Developments
  • Table 76. Roche Company Details
  • Table 77. Roche Business Overview
  • Table 78. Roche Cancer Diagnostics Product
  • Table 79. Roche Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million)
  • Table 80. Roche Recent Developments
  • Table 81. Thermo Fisher Scientific Company Details
  • Table 82. Thermo Fisher Scientific Business Overview
  • Table 83. Thermo Fisher Scientific Cancer Diagnostics Product
  • Table 84. Thermo Fisher Scientific Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million)
  • Table 85. Thermo Fisher Scientific Recent Developments
  • Table 86. Agilent Technologies Company Details
  • Table 87. Agilent Technologies Business Overview
  • Table 88. Agilent Technologies Cancer Diagnostics Product
  • Table 89. Agilent Technologies Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million)
  • Table 90. Agilent Technologies Recent Developments
  • Table 91. Illumina Company Details
  • Table 92. Illumina Business Overview
  • Table 93. Illumina Cancer Diagnostics Product
  • Table 94. Illumina Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million)
  • Table 95. Illumina Recent Developments
  • Table 96. Siemens Healthcare Company Details
  • Table 97. Siemens Healthcare Business Overview
  • Table 98. Siemens Healthcare Cancer Diagnostics Product
  • Table 99. Siemens Healthcare Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million)
  • Table 100. Siemens Healthcare Recent Developments
  • Table 101. C.R. Bard Company Details
  • Table 102. C.R. Bard Business Overview
  • Table 103. C.R. Bard Cancer Diagnostics Product
  • Table 104. C.R. Bard Revenue in Cancer Diagnostics Business (2017-2022) & (US$ Million)
  • Table 105. C.R. Bard Recent Developments
  • Table 106. Research Programs/Design for This Report
  • Table 107. Key Data Information from Secondary Sources
  • Table 108. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Cancer Diagnostics Market Share by Type: 2021 VS 2028
  • Figure 2. Platform-based Features
  • Figure 3. Instrument-based Features
  • Figure 4. Global Cancer Diagnostics Market Share by Application: 2021 VS 2028
  • Figure 5. Breast Cancer Case Studies
  • Figure 6. Lung Cancer Case Studies
  • Figure 7. Colorectal Cancer Case Studies
  • Figure 8. Others Case Studies
  • Figure 9. Cancer Diagnostics Report Years Considered
  • Figure 10. Global Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 11. Global Cancer Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 12. Global Cancer Diagnostics Market Share by Region: 2021 VS 2028
  • Figure 13. Global Cancer Diagnostics Market Share by Players in 2021
  • Figure 14. Global Top Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Diagnostics as of 2021)
  • Figure 15. The Top 10 and 5 Players Market Share by Cancer Diagnostics Revenue in 2021
  • Figure 16. North America Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 17. North America Cancer Diagnostics Market Size Market Share by Type (2017-2028)
  • Figure 18. North America Cancer Diagnostics Market Size Market Share by Application (2017-2028)
  • Figure 19. North America Cancer Diagnostics Market Size Share by Country (2017-2028)
  • Figure 20. United States Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 21. Canada Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. Europe Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 23. Europe Cancer Diagnostics Market Size Market Share by Type (2017-2028)
  • Figure 24. Europe Cancer Diagnostics Market Size Market Share by Application (2017-2028)
  • Figure 25. Europe Cancer Diagnostics Market Size Share by Country (2017-2028)
  • Figure 26. Germany Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. France Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. U.K. Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Italy Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Russia Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Nordic Countries Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Asia-Pacific Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 33. Asia Pacific Cancer Diagnostics Market Size Market Share by Type (2017-2028)
  • Figure 34. Asia Pacific Cancer Diagnostics Market Size Market Share by Application (2017-2028)
  • Figure 35. Asia Pacific Cancer Diagnostics Market Size Share by Region (2017-2028)
  • Figure 36. China Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. Japan Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. South Korea Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Southeast Asia Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. India Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Australia Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 42. Latin America Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 43. Latin America Cancer Diagnostics Market Size Market Share by Type (2017-2028)
  • Figure 44. Latin America Cancer Diagnostics Market Size Market Share by Application (2017-2028)
  • Figure 45. Latin America Cancer Diagnostics Market Size Share by Country (2017-2028)
  • Figure 46. Mexico Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 47. Brazil Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 48. Middle East & Africa Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 49. Middle East and Africa Cancer Diagnostics Market Size Market Share by Type (2017-2028)
  • Figure 50. Middle East and Africa Cancer Diagnostics Market Size Market Share by Application (2017-2028)
  • Figure 51. Middle East and Africa Cancer Diagnostics Market Size Share by Country (2017-2028)
  • Figure 52. Turkey Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. Saudi Arabia Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. UAE Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. Becton, Dickinson and Company Revenue Growth Rate in Cancer Diagnostics Business (2017-2022)
  • Figure 56. GE Healthcare Revenue Growth Rate in Cancer Diagnostics Business (2017-2022)
  • Figure 57. Abbott Revenue Growth Rate in Cancer Diagnostics Business (2017-2022)
  • Figure 58. Roche Revenue Growth Rate in Cancer Diagnostics Business (2017-2022)
  • Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Cancer Diagnostics Business (2017-2022)
  • Figure 60. Agilent Technologies Revenue Growth Rate in Cancer Diagnostics Business (2017-2022)
  • Figure 61. Illumina Revenue Growth Rate in Cancer Diagnostics Business (2017-2022)
  • Figure 62. Siemens Healthcare Revenue Growth Rate in Cancer Diagnostics Business (2017-2022)
  • Figure 63. C.R. Bard Revenue Growth Rate in Cancer Diagnostics Business (2017-2022)
  • Figure 64. Bottom-up and Top-down Approaches for This Report
  • Figure 65. Data Triangulation
  • Figure 66. Key Executives Interviewed
目次

This research report focuses on the Cancer Diagnostics Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Cancer Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Platform-based
    • 1.2.3 Instrument-based
  • 1.3 Market by Application
    • 1.3.1 Global Cancer Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Breast Cancer
    • 1.3.3 Lung Cancer
    • 1.3.4 Colorectal Cancer
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Cancer Diagnostics Market Perspective (2017-2028)
  • 2.2 Cancer Diagnostics Growth Trends by Region
    • 2.2.1 Cancer Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Cancer Diagnostics Historic Market Size by Region (2017-2022)
    • 2.2.3 Cancer Diagnostics Forecasted Market Size by Region (2023-2028)
  • 2.3 Cancer Diagnostics Market Dynamics
    • 2.3.1 Cancer Diagnostics Industry Trends
    • 2.3.2 Cancer Diagnostics Market Drivers
    • 2.3.3 Cancer Diagnostics Market Challenges
    • 2.3.4 Cancer Diagnostics Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Cancer Diagnostics Players by Revenue
    • 3.1.1 Global Top Cancer Diagnostics Players by Revenue (2017-2022)
    • 3.1.2 Global Cancer Diagnostics Revenue Market Share by Players (2017-2022)
  • 3.2 Global Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Cancer Diagnostics Revenue
  • 3.4 Global Cancer Diagnostics Market Concentration Ratio
    • 3.4.1 Global Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Cancer Diagnostics Revenue in 2021
  • 3.5 Cancer Diagnostics Key Players Head office and Area Served
  • 3.6 Key Players Cancer Diagnostics Product Solution and Service
  • 3.7 Date of Enter into Cancer Diagnostics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Diagnostics Breakdown Data by Type

  • 4.1 Global Cancer Diagnostics Historic Market Size by Type (2017-2022)
  • 4.2 Global Cancer Diagnostics Forecasted Market Size by Type (2023-2028)

5 Cancer Diagnostics Breakdown Data by Application

  • 5.1 Global Cancer Diagnostics Historic Market Size by Application (2017-2022)
  • 5.2 Global Cancer Diagnostics Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Cancer Diagnostics Market Size (2017-2028)
  • 6.2 North America Cancer Diagnostics Market Size by Type
    • 6.2.1 North America Cancer Diagnostics Market Size by Type (2017-2022)
    • 6.2.2 North America Cancer Diagnostics Market Size by Type (2023-2028)
    • 6.2.3 North America Cancer Diagnostics Market Share by Type (2017-2028)
  • 6.3 North America Cancer Diagnostics Market Size by Application
    • 6.3.1 North America Cancer Diagnostics Market Size by Application (2017-2022)
    • 6.3.2 North America Cancer Diagnostics Market Size by Application (2023-2028)
    • 6.3.3 North America Cancer Diagnostics Market Share by Application (2017-2028)
  • 6.4 North America Cancer Diagnostics Market Size by Country
    • 6.4.1 North America Cancer Diagnostics Market Size by Country (2017-2022)
    • 6.4.2 North America Cancer Diagnostics Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Cancer Diagnostics Market Size (2017-2028)
  • 7.2 Europe Cancer Diagnostics Market Size by Type
    • 7.2.1 Europe Cancer Diagnostics Market Size by Type (2017-2022)
    • 7.2.2 Europe Cancer Diagnostics Market Size by Type (2023-2028)
    • 7.2.3 Europe Cancer Diagnostics Market Share by Type (2017-2028)
  • 7.3 Europe Cancer Diagnostics Market Size by Application
    • 7.3.1 Europe Cancer Diagnostics Market Size by Application (2017-2022)
    • 7.3.2 Europe Cancer Diagnostics Market Size by Application (2023-2028)
    • 7.3.3 Europe Cancer Diagnostics Market Share by Application (2017-2028)
  • 7.4 Europe Cancer Diagnostics Market Size by Country
    • 7.4.1 Europe Cancer Diagnostics Market Size by Country (2017-2022)
    • 7.4.2 Europe Cancer Diagnostics Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Cancer Diagnostics Market Size (2017-2028)
  • 8.2 Asia-Pacific Cancer Diagnostics Market Size by Type
    • 8.2.1 Asia-Pacific Cancer Diagnostics Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Cancer Diagnostics Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Cancer Diagnostics Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Cancer Diagnostics Market Size by Application
    • 8.3.1 Asia-Pacific Cancer Diagnostics Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Cancer Diagnostics Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Cancer Diagnostics Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Cancer Diagnostics Market Size by Region
    • 8.4.1 Asia-Pacific Cancer Diagnostics Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Cancer Diagnostics Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Cancer Diagnostics Market Size (2017-2028)
  • 9.2 Latin America Cancer Diagnostics Market Size by Type
    • 9.2.1 Latin America Cancer Diagnostics Market Size by Type (2017-2022)
    • 9.2.2 Latin America Cancer Diagnostics Market Size by Type (2023-2028)
    • 9.2.3 Latin America Cancer Diagnostics Market Share by Type (2017-2028)
  • 9.3 Latin America Cancer Diagnostics Market Size by Application
    • 9.3.1 Latin America Cancer Diagnostics Market Size by Application (2017-2022)
    • 9.3.2 Latin America Cancer Diagnostics Market Size by Application (2023-2028)
    • 9.3.3 Latin America Cancer Diagnostics Market Share by Application (2017-2028)
  • 9.4 Latin America Cancer Diagnostics Market Size by Country
    • 9.4.1 Latin America Cancer Diagnostics Market Size by Country (2017-2022)
    • 9.4.2 Latin America Cancer Diagnostics Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Cancer Diagnostics Market Size (2017-2028)
  • 10.2 Middle East & Africa Cancer Diagnostics Market Size by Type
    • 10.2.1 Middle East & Africa Cancer Diagnostics Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Cancer Diagnostics Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Cancer Diagnostics Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Cancer Diagnostics Market Size by Application
    • 10.3.1 Middle East & Africa Cancer Diagnostics Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Cancer Diagnostics Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Cancer Diagnostics Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Cancer Diagnostics Market Size by Country
    • 10.4.1 Middle East & Africa Cancer Diagnostics Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Cancer Diagnostics Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Becton, Dickinson and Company
    • 11.1.1 Becton, Dickinson and Company Company Details
    • 11.1.2 Becton, Dickinson and Company Business Overview
    • 11.1.3 Becton, Dickinson and Company Cancer Diagnostics Introduction
    • 11.1.4 Becton, Dickinson and Company Revenue in Cancer Diagnostics Business (2017-2022)
    • 11.1.5 Becton, Dickinson and Company Recent Developments
  • 11.2 GE Healthcare
    • 11.2.1 GE Healthcare Company Details
    • 11.2.2 GE Healthcare Business Overview
    • 11.2.3 GE Healthcare Cancer Diagnostics Introduction
    • 11.2.4 GE Healthcare Revenue in Cancer Diagnostics Business (2017-2022)
    • 11.2.5 GE Healthcare Recent Developments
  • 11.3 Abbott
    • 11.3.1 Abbott Company Details
    • 11.3.2 Abbott Business Overview
    • 11.3.3 Abbott Cancer Diagnostics Introduction
    • 11.3.4 Abbott Revenue in Cancer Diagnostics Business (2017-2022)
    • 11.3.5 Abbott Recent Developments
  • 11.4 Roche
    • 11.4.1 Roche Company Details
    • 11.4.2 Roche Business Overview
    • 11.4.3 Roche Cancer Diagnostics Introduction
    • 11.4.4 Roche Revenue in Cancer Diagnostics Business (2017-2022)
    • 11.4.5 Roche Recent Developments
  • 11.5 Thermo Fisher Scientific
    • 11.5.1 Thermo Fisher Scientific Company Details
    • 11.5.2 Thermo Fisher Scientific Business Overview
    • 11.5.3 Thermo Fisher Scientific Cancer Diagnostics Introduction
    • 11.5.4 Thermo Fisher Scientific Revenue in Cancer Diagnostics Business (2017-2022)
    • 11.5.5 Thermo Fisher Scientific Recent Developments
  • 11.6 Agilent Technologies
    • 11.6.1 Agilent Technologies Company Details
    • 11.6.2 Agilent Technologies Business Overview
    • 11.6.3 Agilent Technologies Cancer Diagnostics Introduction
    • 11.6.4 Agilent Technologies Revenue in Cancer Diagnostics Business (2017-2022)
    • 11.6.5 Agilent Technologies Recent Developments
  • 11.7 Illumina
    • 11.7.1 Illumina Company Details
    • 11.7.2 Illumina Business Overview
    • 11.7.3 Illumina Cancer Diagnostics Introduction
    • 11.7.4 Illumina Revenue in Cancer Diagnostics Business (2017-2022)
    • 11.7.5 Illumina Recent Developments
  • 11.8 Siemens Healthcare
    • 11.8.1 Siemens Healthcare Company Details
    • 11.8.2 Siemens Healthcare Business Overview
    • 11.8.3 Siemens Healthcare Cancer Diagnostics Introduction
    • 11.8.4 Siemens Healthcare Revenue in Cancer Diagnostics Business (2017-2022)
    • 11.8.5 Siemens Healthcare Recent Developments
  • 11.9 C.R. Bard
    • 11.9.1 C.R. Bard Company Details
    • 11.9.2 C.R. Bard Business Overview
    • 11.9.3 C.R. Bard Cancer Diagnostics Introduction
    • 11.9.4 C.R. Bard Revenue in Cancer Diagnostics Business (2017-2022)
    • 11.9.5 C.R. Bard Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer